Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts Inc (NQ: TMCI )

23.50 +0.41 (+1.78%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 308,372
Open 23.13
Bid (Size) 9.400 (2)
Ask (Size) 26.58 (2)
Prev. Close 23.09
Today's Range 22.93 - 23.99
52wk Range 12.48 - 26.50
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
NASDAQ:TMCI Shareholder Alert: Investigation over Potential Wrongdoing at Treace Medical Concepts, Inc.
San Diego, CA -- (SBWIRE) -- 01/27/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Treace Medical Concepts, Inc. 
Via SBWire
Treace Medical Concepts Provides 2022 Preliminary Unaudited Revenue
From Treace Medical Concepts, Inc.
Via Globe NewsWire

Performance

YTD
+4.96%
+4.96%
1 Month
+4.96%
+4.96%
3 Month
+3.57%
+3.57%
6 Month
+23.23%
+23.23%
1 Year
+26.48%
+26.48%

More News

Read More
Bragar Eagel & Squire, P.C. Is Investigating BRP, Alico, Treace, and Welltower and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
5 Analysts Have This to Say About Treace Medical Concepts
Via Benzinga
Treace to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023
From Treace Medical Concepts, Inc.
Via Globe NewsWire
Treace Medical Announces Expansion of Its Global IP Portfolio with the Grant of Two New U.S. Patents
From Treace Medical Concepts, Inc.
Via Globe NewsWire
NASDAQ:TMCI Investor Notice: Investigation over Possible Securities Laws Violations by Treace Medical Concepts, Inc.
Via SBWire
Treace Medical Shares Interim Data From Corrective Toe Surgery Trial
Via Benzinga
Treace Receives FDA 510(k) Clearance for SpeedPlate™ Rapid Compression Implant Technology
From Treace Medical Concepts, Inc.
Via Globe NewsWire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Treace Medical Concepts, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Treace Announces First Patient Treated in MTA3D™ Adductoplasty® Clinical Study
From Treace Medical Concepts, Inc.
Via Globe NewsWire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Treace Medical Concepts, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Vodafone, Getty Images Holdings, Haynes International And Some Other Big Stocks Moving Lower On Tuesday
Via Benzinga
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
Via Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Treace Medical Concepts Reports Third Quarter 2022 Financial Results
From Treace Medical Concepts, Inc.
Via Globe NewsWire
Earnings Scheduled For November 8, 2022
Via Benzinga
Treace Announces Participation in Upcoming Investor Conferences
From Treace Medical Concepts, Inc.
Via Globe NewsWire
Treace to Report Third Quarter 2022 Financial Results on November 8, 2022
From Treace Medical Concepts, Inc.
Via Globe NewsWire
Treace Medical Concepts Appoints New Directors
From Treace Medical Concepts, Inc.
Via Globe NewsWire
Where Treace Medical Concepts Stands With Analysts
Via Benzinga
Recap: Treace Medical Concepts Q2 Earnings
Via Benzinga
Earnings Scheduled For August 9, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.